Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Anti-Anginal Effects of N-Acetylcysteine (NAC) in Patients with Angina and Non-Obstructive Coronary Arteries (ANOCA)

NCT06890507 is registered in ClinicalTrials.gov with University of Adelaide as lead sponsor.

NCT NCT06890507
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06890507 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Anti-Anginal Effects of N-Acetylcysteine (NAC) in Patients with Angina and Non-Obstructive Coronary Arteries (ANOCA)
Lead sponsor
University of Adelaide
Phase
Phase 2
Overall status
Not yet recruiting
Start date
June 1, 2025
Completion date
September 1, 2027
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angina attacks, non obstructive coronary artery disease